Meclofenamic acid
CAS No. 644-62-2
Meclofenamic acid( Meclofenamate )
Catalog No. M26293 CAS No. 644-62-2
Meclofenamic acid is a non-selective gap-junction blocker and a selective fat mass and obesity-associated (FTO) enzyme inhibitor. Meclofenamic acid has anti-inflammatory activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 659 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMeclofenamic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionMeclofenamic acid is a non-selective gap-junction blocker and a selective fat mass and obesity-associated (FTO) enzyme inhibitor. Meclofenamic acid has anti-inflammatory activities.
-
DescriptionMeclofenamic acid is a non-selective gap-junction blocker and a selective fat mass and obesity-associated (FTO) enzyme inhibitor. Meclofenamic acid has anti-inflammatory activities.
-
In VitroMeclofenamic acid (0-100 μM, 24 h) inhibits FTO demethylation in a dose-response manner.Meclofenamic acid inhibits enzyme cyclooxygenase, with an IC50 about 1 μM, thereby inhibiting the production of prostaglandins.Meclofenamic acid inhibits the release of 5-HETE and LTB4 from human neutrophils stimulated with calcium ionophore and antagonizes the response of tissues to certain prostaglandins. Western Blot Analysis Cell Line:HeLa cells Concentration:0, 12.5, 25, 50, 100 μM Incubation Time:24 h Result:Inhibited FTO demethylation in a dose-response manner, and elevates the levels of cellular m6A in mRNA by targeting FTO.
-
In Vivo——
-
SynonymsMeclofenamate
-
PathwayOthers
-
TargetOther Targets
-
RecptorMajor prion protein
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number644-62-2
-
Formula Weight296.15
-
Molecular FormulaC14H11Cl2NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (337.67 mM)
-
SMILESCc1ccc(Cl)c(Nc2ccccc2C(O)=O)c1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kimata A, et al. New series of antiprion compounds: pyrazolone derivatives have the potent activity of inhibiting protease-resistant prion protein accumulation [published correction appears in J Med Chem. 2008 Mar 13;51(5):1503]. J Med Chem. 2007;50(21):5053-5056.
molnova catalog
related products
-
[Lys0] g-1-MSH, amid...
[Lys0] g-1-MSH, amide
-
3,8-Di-O-methylellag...
3,3'-Di-O-methylellagic acid reveals moderate antibacterial activity, it also shows strong DPPH radical scavenging activities with SC50 of 123.3 ug/mL.
-
Jujuboside B
Jujuboside B has potent inhibitory effects on collagen-, thrombin-, AA-, and ADP-induced aggregation, and also exhibits superior protection on the thromboembolic model.
Cart
sales@molnova.com